Premature senescence and cellular phenotype transformation of mesangial cells induced by TGF-B₁

References

• Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1987;1:272–281
   PubMed Web of Science ®Google Scholar
• Jiao S, Meng F, Zhang J, Yang X, Zheng X, Wang L. STAT1 mediates cellular senescence induced by angiotensin II and H2O2 in human glomerular mesangial cells. Mol Cell Biochem. 2012;365:9–17
   Google Scholar
• Aihara K, Ikeda Y, Yagi S, Akaike M, Matsumoto T. Transforming growth factor-beta1 as a common target molecule for development of cardiovascular diseases, renal insufficiency and metabolic syndrome. Cardiol Res Pract. 2011;2011:175381 9 pp. doi: 10.4061/2011/175381.
   Google Scholar
• Desmouliere A, Darby IA, Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest. 2003;83:1689–1707
   PubMed Web of Science ®Google Scholar
• Schnaper HW, Jandeska S, Runyan CE, et al. TGF-beta signal transduction in chronic kidney disease. Front Biosci. 2009;14:2448–2465
   Web of Science ®Google Scholar
• Lopez-Novoa JM, Rodriguez-Pena AB, Ortiz A, Martinez-Salgado C, Lopez Hernandez FJ. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med. 2011;9:13. 24 pp
   PubMedGoogle Scholar
• Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW. TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 1999;56:1710–1720
   PubMed Web of Science ®Google Scholar
• Dorado F, Velasco S, Esparis-Ogando A, et al. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation. Nephrol Dial Transplant. 2008;23:3403–3411
   Google Scholar
• Kimura K, Iwano M. Molecular mechanisms of tissue fibrosis. Nihon Rinsho Meneki Gakkai Kaishi. 2009;32:160–167
   Google Scholar
• Lee DH, Wolstein JM, Pudasaini B, Plotkin M. INK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2012;302:F183–F191
   Google Scholar
• Verzola D, Gandolfo MT, Gaetani G, et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 2008;295:F1563–F1573
   Google Scholar
• Koppelstaetter C, Schratzberger G, Perco P, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell. 2008;7:491–497
   PubMed Web of Science ®Google Scholar
• Braun H, Schmidt BM, Raiss M, et al. Cellular senescence limits regenerative capacity and allograft survival. J Am Soc Nephrol. 2012;23:1467–1473
   PubMed Web of Science ®Google Scholar
• Sis B, Tasanarong A, Khoshjou F, Dadras F, Solez K, Halloran PF. Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int. 2007;71:218–226
   PubMed Web of Science ®Google Scholar
• Sterzel RB, Schulze-Lohoff E, Marx M. Cytokines and mesangial cells. Kidney Int Suppl. 1993;39:S26–S31
   Google Scholar
• Das F, Ghosh-Choudhury N, Kasinath BS, Choudhury GG. TGFbeta enforces activation of eukaryotic elongation factor-2 (eEF2) via inactivation of eEF2 kinase by p90 ribosomal S6 kinase (p90Rsk) to induce mesangial cell hypertrophy. FEBS Lett. 2010;584:4268–4272
   Google Scholar
• Stephenson LA, Haney LB, Hussaini IM, Karns LR, Glass WF 2nd. Regulation of smooth muscle alpha-actin expression and hypertrophy in cultured mesangial cells. Kidney Int. 1998;54:1175–1187
   Google Scholar
• Bariety J, Hill GS, Mandet C, et al. Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant. 2003;18:1777–1784
   Google Scholar
• Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando). 2008;22:1–5
   PubMedGoogle Scholar
• Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol. 2011;179:1074–1080
   PubMed Web of Science ®Google Scholar
• Li J, Bertram JF. Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology (Carlton). 2010;15:507–512
   PubMed Web of Science ®Google Scholar
• Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol. 2009;175:1380–1388
   PubMed Web of Science ®Google Scholar